Fluocinolone acetonide/hydroquinone/tretinoin

Drug Profile

Fluocinolone acetonide/hydroquinone/tretinoin

Alternative Names: Hydroquinone/tretinoin/fluocinolone-acetonide; Tri-Luma

Latest Information Update: 10 Apr 2003

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Hill Dermaceuticals
  • Developer Galderma
  • Class Fluorinated steroids; Hydroquinones; Pregnadienes; Retinoids; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Melanosis

Most Recent Events

  • 10 Apr 2003 Data presented at the 61st Annual Meeting of the American Academy of Dermatology (AAD-2003) have been added to the adverse events and Skin Disorders therapeutic trials section
  • 29 Apr 2002 Data from a media release have been added to the adverse events and Skin disorders therapeutic trials sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top